| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.67e-05 | 171 | 139 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.98e-05 | 26 | 139 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.98e-05 | 26 | 139 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.14e-04 | 14 | 139 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | adenosine-phosphate deaminase activity | 1.44e-04 | 3 | 139 | 2 | GO:0047623 | |
| GeneOntologyMolecularFunction | AMP deaminase activity | 1.44e-04 | 3 | 139 | 2 | GO:0003876 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5W2 OR51T1 VN1R5 MRGPRD GPR26 OR7C2 OR1F2P SSTR4 GPR139 OR6A2 GPR61 OR1I1 OR3A3 SCTR TACR2 OR9A2 | 4.41e-04 | 884 | 139 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | sodium channel activity | 4.70e-04 | 52 | 139 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 4.75e-04 | 5 | 139 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 4.75e-04 | 5 | 139 | 2 | GO:0008294 | |
| GeneOntologyBiologicalProcess | cilium movement | STK36 BBS1 BBS2 CFAP54 RABL2B RABL2A DNAH12 TACR2 ATP1A4 DYNC1H1 | 1.06e-05 | 261 | 138 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | photoreceptor cell morphogenesis | 2.39e-05 | 9 | 138 | 3 | GO:0008594 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.09e-05 | 208 | 138 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 8.64e-05 | 210 | 138 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.00e-04 | 275 | 138 | 9 | GO:0006814 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.02e-04 | 215 | 138 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.02e-04 | 215 | 138 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | STK36 IFT172 BBS1 BBS2 CFAP54 RABL2B RABL2A DNAH12 TACR2 ATP1A4 DYNC1H1 PCM1 | 1.22e-04 | 493 | 138 | 12 | GO:0007018 |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 1.50e-04 | 119 | 138 | 6 | GO:0006892 | |
| GeneOntologyCellularComponent | sperm midpiece | 4.06e-06 | 64 | 138 | 6 | GO:0097225 | |
| GeneOntologyCellularComponent | cilium | TNPO1 ANKS6 IFT172 RTTN BBS1 BBS2 ADCY5 ADCY6 ADGB CFAP54 RABL2B RABL2A DNAH12 TACR2 TMEM262 ATP1A4 USP48 RAB27A PCM1 | 7.21e-06 | 898 | 138 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | motile cilium | IFT172 BBS1 BBS2 ADGB RABL2B RABL2A DNAH12 TACR2 TMEM262 ATP1A4 | 1.27e-04 | 355 | 138 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.79e-04 | 17 | 138 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | node of Ranvier | 2.96e-04 | 20 | 138 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | ciliary basal body | 3.19e-04 | 195 | 138 | 7 | GO:0036064 | |
| GeneOntologyCellularComponent | intraciliary transport particle B | 3.43e-04 | 21 | 138 | 3 | GO:0030992 | |
| GeneOntologyCellularComponent | protein phosphatase 4 complex | 6.38e-04 | 6 | 138 | 2 | GO:0030289 | |
| GeneOntologyCellularComponent | intraciliary transport particle | 8.17e-04 | 28 | 138 | 3 | GO:0030990 | |
| GeneOntologyCellularComponent | pericentriolar material | 8.17e-04 | 28 | 138 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | axon initial segment | 9.07e-04 | 29 | 138 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.07e-04 | 29 | 138 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | 90S preribosome | 9.07e-04 | 29 | 138 | 3 | GO:0030686 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.04e-03 | 238 | 138 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | BBSome | 1.18e-03 | 8 | 138 | 2 | GO:0034464 | |
| HumanPheno | Cortical dysplasia | 1.30e-05 | 56 | 49 | 6 | HP:0002539 | |
| MousePheno | abnormal cholangiocyte morphology | 8.34e-06 | 6 | 106 | 3 | MP:0012236 | |
| MousePheno | increased circulating triglyceride level | 2.96e-05 | 262 | 106 | 10 | MP:0001552 | |
| Domain | Na_trans_cytopl | 7.11e-06 | 6 | 134 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 7.11e-06 | 6 | 134 | 3 | IPR024583 | |
| Domain | ARM-type_fold | TNPO1 STK36 IFT172 RTTN INTS1 XPO4 HUWE1 RYR3 PPP4R3A DOCK5 UTP20 | 3.38e-05 | 339 | 134 | 11 | IPR016024 |
| Domain | Na_channel_asu | 4.18e-05 | 10 | 134 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 4.18e-05 | 10 | 134 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 4.18e-05 | 10 | 134 | 3 | PF06512 | |
| Domain | KSR1-SAM | 5.11e-05 | 2 | 134 | 2 | PF13543 | |
| Domain | Secretoglobin_1C1/2 | 5.11e-05 | 2 | 134 | 2 | IPR028659 | |
| Domain | KSR_SAM-like_dom | 5.11e-05 | 2 | 134 | 2 | IPR025561 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5W2 OR51T1 VN1R5 MRGPRD GPR26 OR7C2 OR1F2P SSTR4 GPR139 OR6A2 GPR61 OR1I1 OR3A3 TACR2 OR9A2 | 1.20e-04 | 685 | 134 | 15 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5W2 OR51T1 VN1R5 MRGPRD GPR26 OR7C2 OR1F2P SSTR4 GPR139 OR6A2 GPR61 OR1I1 OR3A3 TACR2 OR9A2 | 1.32e-04 | 691 | 134 | 15 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5W2 OR51T1 VN1R5 MRGPRD GPR26 OR7C2 OR1F2P SSTR4 GPR139 OR6A2 GPR61 OR1I1 OR3A3 TACR2 OR9A2 | 1.34e-04 | 692 | 134 | 15 | IPR000276 |
| Domain | AMPD | 1.53e-04 | 3 | 134 | 2 | IPR006329 | |
| Domain | Cat_AA_permease | 1.53e-04 | 3 | 134 | 2 | IPR004755 | |
| Domain | Ion_trans_dom | 1.72e-04 | 114 | 134 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.72e-04 | 114 | 134 | 6 | PF00520 | |
| Domain | IQ | 2.92e-04 | 81 | 134 | 5 | SM00015 | |
| Domain | A/AMP_deam_AS | 3.04e-04 | 4 | 134 | 2 | IPR006650 | |
| Domain | 7tm_1 | OR5W2 OR51T1 MRGPRD GPR26 OR7C2 OR1F2P SSTR4 GPR139 OR6A2 GPR61 OR1I1 OR3A3 TACR2 OR9A2 | 3.66e-04 | 677 | 134 | 14 | PF00001 |
| Domain | IQ_motif_EF-hand-BS | 4.76e-04 | 90 | 134 | 5 | IPR000048 | |
| Domain | CAT3 | 5.04e-04 | 5 | 134 | 2 | IPR015606 | |
| Domain | AA_permease_C | 5.04e-04 | 5 | 134 | 2 | PF13906 | |
| Domain | CAT_C | 5.04e-04 | 5 | 134 | 2 | IPR029485 | |
| Domain | IQ | 5.53e-04 | 93 | 134 | 5 | PS50096 | |
| Domain | Channel_four-helix_dom | 7.45e-04 | 57 | 134 | 4 | IPR027359 | |
| Domain | - | 7.45e-04 | 57 | 134 | 4 | 1.20.120.350 | |
| Domain | Adcy_conserved_dom | 7.52e-04 | 6 | 134 | 2 | IPR009398 | |
| Domain | A_DEAMINASE | 7.52e-04 | 6 | 134 | 2 | PS00485 | |
| Domain | DUF1053 | 7.52e-04 | 6 | 134 | 2 | PF06327 | |
| Domain | A_deaminase | 7.52e-04 | 6 | 134 | 2 | PF00962 | |
| Domain | P-type_ATPase_IIC | 7.52e-04 | 6 | 134 | 2 | IPR005775 | |
| Domain | A/AMP_deaminase_dom | 7.52e-04 | 6 | 134 | 2 | IPR001365 | |
| Domain | DUSP | 1.05e-03 | 7 | 134 | 2 | PS51283 | |
| Domain | - | 1.05e-03 | 7 | 134 | 2 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 1.05e-03 | 7 | 134 | 2 | IPR006615 | |
| Domain | GPCR_Rhodpsn_7TM | OR5W2 OR51T1 MRGPRD GPR26 OR7C2 SSTR4 GPR139 OR6A2 GPR61 OR1I1 OR3A3 TACR2 OR9A2 | 1.07e-03 | 670 | 134 | 13 | IPR017452 |
| Domain | AC_N | 1.39e-03 | 8 | 134 | 2 | IPR032628 | |
| Domain | Adcy | 1.39e-03 | 8 | 134 | 2 | IPR030672 | |
| Domain | AC_N | 1.39e-03 | 8 | 134 | 2 | PF16214 | |
| Domain | SCGB | 1.78e-03 | 9 | 134 | 2 | PS51311 | |
| Domain | RAB | 1.88e-03 | 73 | 134 | 4 | PS51419 | |
| Domain | Uteroglobin | 2.21e-03 | 10 | 134 | 2 | PF01099 | |
| Domain | Secretoglobin | 2.69e-03 | 11 | 134 | 2 | IPR016126 | |
| Domain | DHR-1_domain | 2.69e-03 | 11 | 134 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.69e-03 | 11 | 134 | 2 | PS51651 | |
| Domain | DHR_1 | 2.69e-03 | 11 | 134 | 2 | PS51650 | |
| Domain | DHR-2 | 2.69e-03 | 11 | 134 | 2 | PF06920 | |
| Domain | DOCK | 2.69e-03 | 11 | 134 | 2 | IPR026791 | |
| Domain | DOCK_C | 2.69e-03 | 11 | 134 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.69e-03 | 11 | 134 | 2 | PF14429 | |
| Domain | DHR-2 | 2.69e-03 | 11 | 134 | 2 | IPR027357 | |
| Domain | ARM-like | 3.38e-03 | 270 | 134 | 7 | IPR011989 | |
| Domain | AA_permease_2 | 3.78e-03 | 13 | 134 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 3.78e-03 | 13 | 134 | 2 | IPR002293 | |
| Domain | Znf_hrmn_rcpt | 4.38e-03 | 46 | 134 | 3 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 4.38e-03 | 46 | 134 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 4.38e-03 | 46 | 134 | 3 | PS00031 | |
| Domain | ZnF_C4 | 4.38e-03 | 46 | 134 | 3 | SM00399 | |
| Domain | zf-C4 | 4.38e-03 | 46 | 134 | 3 | PF00105 | |
| Domain | Nuclear_hrmn_rcpt | 4.38e-03 | 46 | 134 | 3 | IPR001723 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.39e-03 | 14 | 134 | 2 | IPR024317 | |
| Domain | VitD_rcpt | 4.39e-03 | 14 | 134 | 2 | IPR000324 | |
| Domain | Dynein_heavy_dom-2 | 4.39e-03 | 14 | 134 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.39e-03 | 14 | 134 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.39e-03 | 14 | 134 | 2 | IPR011704 | |
| Domain | AAA_8 | 4.39e-03 | 14 | 134 | 2 | PF12780 | |
| Domain | uDENN | 4.39e-03 | 14 | 134 | 2 | SM00800 | |
| Domain | AAA_5 | 4.39e-03 | 14 | 134 | 2 | PF07728 | |
| Domain | - | 4.65e-03 | 47 | 134 | 3 | 1.10.565.10 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 4.93e-03 | 48 | 134 | 3 | IPR000536 | |
| Domain | HOLI | 4.93e-03 | 48 | 134 | 3 | SM00430 | |
| Domain | Hormone_recep | 4.93e-03 | 48 | 134 | 3 | PF00104 | |
| Domain | HEAT | 4.93e-03 | 48 | 134 | 3 | PF02985 | |
| Domain | DHC_fam | 5.05e-03 | 15 | 134 | 2 | IPR026983 | |
| Domain | uDENN | 5.05e-03 | 15 | 134 | 2 | PF03456 | |
| Domain | Dynein_heavy | 5.05e-03 | 15 | 134 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.05e-03 | 15 | 134 | 2 | IPR004273 | |
| Domain | DENN | 5.74e-03 | 16 | 134 | 2 | SM00799 | |
| Domain | MAM_1 | 5.74e-03 | 16 | 134 | 2 | PS00740 | |
| Domain | DENN | 5.74e-03 | 16 | 134 | 2 | PF02141 | |
| Domain | dDENN | 5.74e-03 | 16 | 134 | 2 | PF03455 | |
| Domain | ATPase_P-typ_TM_dom | 5.74e-03 | 16 | 134 | 2 | IPR023298 | |
| Domain | UDENN | 5.74e-03 | 16 | 134 | 2 | PS50946 | |
| Domain | DDENN | 5.74e-03 | 16 | 134 | 2 | PS50947 | |
| Domain | - | 5.74e-03 | 16 | 134 | 2 | 1.20.1110.10 | |
| Domain | dDENN | 5.74e-03 | 16 | 134 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.74e-03 | 16 | 134 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.74e-03 | 16 | 134 | 2 | IPR005113 | |
| Domain | DENN | 5.74e-03 | 16 | 134 | 2 | PS50211 | |
| Domain | DENN_dom | 5.74e-03 | 16 | 134 | 2 | IPR001194 | |
| Domain | ATPase_P-typ_cation-transptr_C | 6.48e-03 | 17 | 134 | 2 | IPR006068 | |
| Domain | A/G_cyclase_CS | 6.48e-03 | 17 | 134 | 2 | IPR018297 | |
| Domain | Cation_ATPase_C | 6.48e-03 | 17 | 134 | 2 | PF00689 | |
| Domain | TPR-like_helical_dom | 6.75e-03 | 233 | 134 | 6 | IPR011990 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL4B TNPO1 TANC2 AMPD2 DENND4A ANKS6 EYA4 IFT172 BBS1 BBS2 XPO4 CLOCK DENND1A ADCY6 PPP4R3A NUP205 DOCK5 STK3 KSR1 DOCK7 NUP133 UBAC2 USP15 DYNC1H1 RUSF1 | 9.48e-11 | 1321 | 139 | 25 | 27173435 |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 32845893 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 28518218 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 17928448 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL4B TNPO1 AMPD2 GNPDA1 ANKFY1 NIF3L1 PSMD11 HUWE1 PPP4R3A NUP205 FASN LUC7L2 FDPS PES1 NUP133 ANP32E MACF1 IKBKB USP48 USP15 FKBP5 DYNC1H1 | 8.02e-08 | 1455 | 139 | 22 | 22863883 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 TANC2 STK36 ANKS6 EP400 RTTN KSR2 INTS1 TRMT11 PPARA ATG2A HUWE1 DENND1A TPCN1 PCNX2 SLC7A1 FASN SCN8A DYNC1H1 | 9.58e-08 | 1105 | 139 | 19 | 35748872 |
| Pubmed | RTTN PSMD11 HUWE1 PPP4R3A NUP205 DOCK5 FASN DNAH12 CCNB3 FER1L4 PES1 MACF1 MYO18B | 1.10e-07 | 496 | 139 | 13 | 31343991 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 17537961 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 35031483 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 29578003 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 21156207 | ||
| Pubmed | CUL4B TNPO1 INTS1 BMS1 HUWE1 NUP205 FASN PES1 DOCK7 NUP133 MACF1 UTP20 DYNC1H1 PCM1 | 4.00e-07 | 653 | 139 | 14 | 22586326 | |
| Pubmed | INTS1 DHRS13 PSMD11 HUWE1 NUP205 KSR1 SLC7A1 FASN CDK5RAP3 GYG1 PES1 NUP133 ADAM17 MCTP2 FKBP5 DYNC1H1 RUSF1 PCM1 | 1.04e-06 | 1168 | 139 | 18 | 19946888 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.24e-06 | 6 | 139 | 3 | 23652591 | |
| Pubmed | HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data. | 1.24e-06 | 6 | 139 | 3 | 27086506 | |
| Pubmed | NUDT19 TNPO1 BMS1 XPO4 PSMD11 HUWE1 DENND1A NUP205 FASN LUC7L2 FDPS PES1 DOCK7 NUP133 ANP32E IKBKB FKBP5 RAB27A DYNC1H1 PCM1 | 1.25e-06 | 1440 | 139 | 20 | 30833792 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 2.16e-06 | 7 | 139 | 3 | 25818041 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TNPO1 TANC2 INTS1 PSMD11 HUWE1 DOCK5 FASN GSDME LUC7L2 MACF1 USP48 DYNC1H1 | 4.18e-06 | 582 | 139 | 12 | 20467437 |
| Pubmed | 5.16e-06 | 9 | 139 | 3 | 16382098 | ||
| Pubmed | 5.16e-06 | 9 | 139 | 3 | 15746173 | ||
| Pubmed | 5.16e-06 | 9 | 139 | 3 | 18762586 | ||
| Pubmed | 6.31e-06 | 172 | 139 | 7 | 27375898 | ||
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 17574030 | ||
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 27979967 | ||
| Pubmed | A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. | 7.34e-06 | 10 | 139 | 3 | 19081074 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 8.76e-06 | 119 | 139 | 6 | 35776542 | |
| Pubmed | 1.01e-05 | 11 | 139 | 3 | 24550735 | ||
| Pubmed | CUL4B TNPO1 ANKFY1 IFT172 PSMD11 HUWE1 PPP4R3A NUP205 FASN PES1 NUP133 DYNC1H1 | 1.05e-05 | 638 | 139 | 12 | 33239621 | |
| Pubmed | 1.13e-05 | 346 | 139 | 9 | 14611657 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.34e-05 | 12 | 139 | 3 | 30175250 | |
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 1.46e-05 | 37 | 139 | 4 | 20937701 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38892470 | ||
| Pubmed | "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. | 1.59e-05 | 2 | 139 | 2 | 16054078 | |
| Pubmed | Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK. | 1.59e-05 | 2 | 139 | 2 | 22801368 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.59e-05 | 2 | 139 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.59e-05 | 2 | 139 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.59e-05 | 2 | 139 | 2 | 10827969 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27732084 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19694741 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35348308 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12677556 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31009605 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.59e-05 | 2 | 139 | 2 | 1317301 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31439038 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28684763 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20138207 | ||
| Pubmed | The importance of cationic amino acid transporter expression in human skin. | 1.59e-05 | 2 | 139 | 2 | 12787129 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17068292 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31943325 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.59e-05 | 2 | 139 | 2 | 15249644 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31162142 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15500444 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9174363 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20431059 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18601978 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 1.59e-05 | 2 | 139 | 2 | 19465131 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21479263 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8195186 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 1.59e-05 | 2 | 139 | 2 | 23735284 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29649454 | ||
| Pubmed | Human cationic amino acid transporters are not affected by direct nitros(yl)ation. | 1.59e-05 | 2 | 139 | 2 | 32008093 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29771182 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23609114 | ||
| Pubmed | Adenylyl cyclase type 5 protein expression during cardiac development and stress. | 1.59e-05 | 2 | 139 | 2 | 19734365 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 36933792 | ||
| Pubmed | Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. | 1.59e-05 | 2 | 139 | 2 | 8385111 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33096315 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21862726 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 1.59e-05 | 2 | 139 | 2 | 17805013 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12554753 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26311622 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33411788 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 10444334 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38092833 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33075816 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22824754 | ||
| Pubmed | Regulation of cationic amino acid transporter (CAT) gene expression. | 1.59e-05 | 2 | 139 | 2 | 8878860 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15064952 | ||
| Pubmed | Renal cancer and malformations in relatives of patients with Bardet-Biedl syndrome. | 1.59e-05 | 2 | 139 | 2 | 11096143 | |
| Pubmed | KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. | 1.59e-05 | 2 | 139 | 2 | 19883615 | |
| Pubmed | Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance. | 1.59e-05 | 2 | 139 | 2 | 28287408 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21377452 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35988420 | ||
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 1.59e-05 | 2 | 139 | 2 | 30578315 | |
| Pubmed | Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. | 1.59e-05 | 2 | 139 | 2 | 18172665 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 36090996 | ||
| Pubmed | Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. | 1.59e-05 | 2 | 139 | 2 | 21282557 | |
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 1.59e-05 | 2 | 139 | 2 | 37665666 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31602405 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17881658 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28180061 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33135363 | ||
| Pubmed | PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine. | 1.59e-05 | 2 | 139 | 2 | 18448072 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 10481931 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30206765 | ||
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 15123669 | ||
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 22500027 | ||
| Pubmed | 2.74e-05 | 15 | 139 | 3 | 37091236 | ||
| Interaction | EPHA1 interactions | 3.01e-06 | 235 | 130 | 10 | int:EPHA1 | |
| Interaction | OPALIN interactions | 8.70e-06 | 209 | 130 | 9 | int:OPALIN | |
| Interaction | CD70 interactions | 1.24e-05 | 166 | 130 | 8 | int:CD70 | |
| Interaction | SCN4B interactions | 1.43e-05 | 8 | 130 | 3 | int:SCN4B | |
| Interaction | PPP2R3C interactions | 1.74e-05 | 50 | 130 | 5 | int:PPP2R3C | |
| Interaction | MYCBP2 interactions | CUL4B HUWE1 NR1D1 TLR10 DOCK5 STK3 DOCK7 MACF1 USP15 DYNC1H1 PCM1 | 1.95e-05 | 355 | 130 | 11 | int:MYCBP2 |
| Interaction | COMTD1 interactions | 4.72e-05 | 200 | 130 | 8 | int:COMTD1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.31e-05 | 9 | 99 | 3 | 1203 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 1.97e-04 | 21 | 99 | 3 | 980 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.94e-04 | 5 | 99 | 2 | 1157 | |
| GeneFamily | RAB like GTPases | 2.94e-04 | 5 | 99 | 2 | 394 | |
| GeneFamily | Adenosine deaminase family | 4.39e-04 | 6 | 99 | 2 | 1302 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 8.13e-04 | 8 | 99 | 2 | 1122 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 8.85e-04 | 78 | 99 | 4 | 262 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.30e-03 | 10 | 99 | 2 | 53 | |
| GeneFamily | Nuclear hormone receptors | 2.44e-03 | 49 | 99 | 3 | 71 | |
| GeneFamily | Secretoglobins | 2.59e-03 | 14 | 99 | 2 | 734 | |
| GeneFamily | Rhomboid family | 2.59e-03 | 14 | 99 | 2 | 926 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-06 | 176 | 138 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.52e-06 | 180 | 138 | 7 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.03e-06 | 188 | 138 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.42e-06 | 193 | 138 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.42e-06 | 193 | 138 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.59e-06 | 195 | 138 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.59e-06 | 195 | 138 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-06 | 196 | 138 | 7 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.19e-05 | 163 | 138 | 6 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 168 | 138 | 6 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 168 | 138 | 6 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 180 | 138 | 6 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 183 | 138 | 6 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 183 | 138 | 6 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-05 | 184 | 138 | 6 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 138 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.92e-05 | 191 | 138 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.92e-05 | 191 | 138 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.01e-05 | 192 | 138 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.01e-05 | 192 | 138 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.10e-05 | 193 | 138 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.10e-05 | 193 | 138 | 6 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.10e-05 | 193 | 138 | 6 | 64a37dae3d631713b06d94691f5dcdb200dfef5e | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.38e-05 | 196 | 138 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.38e-05 | 196 | 138 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 197 | 138 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.47e-05 | 197 | 138 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.47e-05 | 197 | 138 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 198 | 138 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 3.78e-05 | 200 | 138 | 6 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-05 | 145 | 138 | 5 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.00e-06 | 196 | 137 | 9 | 4063_DN | |
| Disease | epilepsy (implicated_via_orthology) | 8.43e-07 | 163 | 134 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.07e-05 | 10 | 134 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.07e-05 | 10 | 134 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.96e-05 | 12 | 134 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Benign familial infantile epilepsy | 6.12e-05 | 3 | 134 | 2 | cv:C5575231 | |
| Disease | Neurodevelopmental Disorders | 6.76e-05 | 93 | 134 | 5 | C1535926 | |
| Disease | Polydactyly | 2.00e-04 | 117 | 134 | 5 | C0152427 | |
| Disease | pontocerebellar hypoplasia (implicated_via_orthology) | 2.03e-04 | 5 | 134 | 2 | DOID:0060264 (implicated_via_orthology) | |
| Disease | Familial benign neonatal epilepsy | 3.03e-04 | 6 | 134 | 2 | C0220669 | |
| Disease | free androgen index | 3.22e-04 | 374 | 134 | 8 | EFO_0007005 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 3.40e-04 | 30 | 134 | 3 | C1868672 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 4.24e-04 | 7 | 134 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 4.24e-04 | 7 | 134 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.24e-04 | 7 | 134 | 2 | C0751057 | |
| Disease | Febrile Convulsions | 7.22e-04 | 9 | 134 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 7.22e-04 | 9 | 134 | 2 | C3502809 | |
| Disease | Mesothelioma | 8.60e-04 | 41 | 134 | 3 | C0025500 | |
| Disease | Muscle Weakness | 8.99e-04 | 10 | 134 | 2 | C0151786 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 8.99e-04 | 10 | 134 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | circadian rhythm | 9.10e-04 | 163 | 134 | 5 | EFO_0004354 | |
| Disease | cocaine use | 1.10e-03 | 11 | 134 | 2 | C3496069 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.10e-03 | 11 | 134 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 1.10e-03 | 11 | 134 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 1.12e-03 | 255 | 134 | 6 | EFO_0009924 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.31e-03 | 12 | 134 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Retinitis Pigmentosa | 1.32e-03 | 104 | 134 | 4 | C0035334 | |
| Disease | fetal genotype effect measurement, body weights and measures | 1.45e-03 | 49 | 134 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 1.45e-03 | 49 | 134 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.55e-03 | 13 | 134 | 2 | C0751122 | |
| Disease | Epilepsy | 1.57e-03 | 109 | 134 | 4 | C0014544 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 1.80e-03 | 14 | 134 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 1.80e-03 | 14 | 134 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | body weight | RTTN KSR2 BBS2 HUWE1 TEX11 DENND1A ADCY5 ADCY6 GPR139 SLC7A1 FASN DNAH12 GYG1 PCM1 | 1.82e-03 | 1261 | 134 | 14 | EFO_0004338 |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.90e-03 | 115 | 134 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | MMR-related febrile seizures | 2.07e-03 | 15 | 134 | 2 | EFO_0006519 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.07e-03 | 15 | 134 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Seasonal Affective Disorder | 2.36e-03 | 16 | 134 | 2 | C0085159 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.36e-03 | 16 | 134 | 2 | C0393706 | |
| Disease | platelet component distribution width | 2.40e-03 | 755 | 134 | 10 | EFO_0007984 | |
| Disease | Obesity | 2.49e-03 | 205 | 134 | 5 | C0028754 | |
| Disease | Glycogen storage disease | 2.66e-03 | 17 | 134 | 2 | cv:C0017919 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 2.66e-03 | 17 | 134 | 2 | C2936862 | |
| Disease | alcoholic hepatitis (biomarker_via_orthology) | 2.99e-03 | 18 | 134 | 2 | DOID:12351 (biomarker_via_orthology) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 2.99e-03 | 18 | 134 | 2 | HP_0002373 | |
| Disease | Bardet-Biedl syndrome | 2.99e-03 | 18 | 134 | 2 | cv:C0752166 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 3.44e-03 | 221 | 134 | 5 | C0011860 | |
| Disease | Profound Mental Retardation | 3.77e-03 | 139 | 134 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 3.77e-03 | 139 | 134 | 4 | C0025363 | |
| Disease | Mental deficiency | 3.77e-03 | 139 | 134 | 4 | C0917816 | |
| Disease | palmitoylcarnitine measurement | 4.06e-03 | 21 | 134 | 2 | EFO_0021044 | |
| Disease | Intellectual Disability | 4.42e-03 | 447 | 134 | 7 | C3714756 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.46e-03 | 22 | 134 | 2 | DOID:2030 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIDSLFIMDQFKAAE | 1031 | Q96L91 | |
| AMNAEFEAAEQFDLL | 236 | Q96FF9 | |
| RLLDEMFDSTASQFL | 396 | Q96N23 | |
| LLMEAEDRLNFLLSE | 2271 | Q96N23 | |
| VADLVLMLIDASFGF | 41 | Q5VTM2 | |
| FEELRQEVALFAAAM | 131 | Q86V21 | |
| NFKFAFRAMVLDLEL | 861 | Q8N7X0 | |
| VMTLNELFARFDKLA | 401 | O43306 | |
| SDIFQAVLFDDELLM | 311 | O60443 | |
| MELLSAAKFFQLEAL | 996 | A6QL63 | |
| DSDMFINVDYLTELL | 156 | Q9Y2C3 | |
| FKELEFLSMANVELS | 41 | Q9BTT0 | |
| NLDTFLDDMNFLLAL | 236 | P23109 | |
| ELLIQAGFDVNFMLD | 331 | A6NK59 | |
| VMTLNELFARFDKLA | 491 | O95622 | |
| LREVFESMNLTAYDL | 456 | Q01433 | |
| VADLVLMLIDASFGF | 146 | Q14692 | |
| AVAALMAFLFDLKAL | 396 | P52569 | |
| IMDTSTFLLRFILDD | 1146 | Q2TAZ0 | |
| FLAFNMDTVDDLAFL | 421 | Q9NUZ1 | |
| FEDSEELAALQMLFS | 106 | Q6GMV1 | |
| GTINEAFLFEDMITL | 1001 | Q8WWL7 | |
| EIQEAFLFFMASILK | 561 | Q7Z401 | |
| DAMGFLLLFDLTNEQ | 91 | P51159 | |
| ANVEEAFFTLARDIM | 156 | Q92930 | |
| LLNRTALFEVMFSEE | 201 | Q6IN85 | |
| EFSAEENFLILTEMA | 291 | Q96RI1 | |
| DEAMAELAIADNVFL | 356 | Q92621 | |
| ELAIADNVFLFLMES | 361 | Q92621 | |
| IFADSECLLLSVMAF | 106 | Q8NH69 | |
| DFMDEIFQELENFSL | 186 | Q9UBK7 | |
| DFMDEIFQELENFSL | 186 | Q9UNT1 | |
| ALSIDDMLVEANFIL | 256 | Q6WBX8 | |
| DMLVEANFILATLAD | 261 | Q6WBX8 | |
| DDVFLTELMKLANRF | 131 | Q9P2R3 | |
| ASESFLLAAFLNLAM | 311 | Q13451 | |
| LAALASDFSEDMLQE | 976 | Q8WUM0 | |
| LRDVASESVALFFML | 36 | Q9BZJ8 | |
| SESVALFFMLLLDLT | 41 | Q9BZJ8 | |
| LEAANLFQFLRMVDA | 146 | Q8WZ60 | |
| FMGSAFVILSDLELN | 271 | Q6DN12 | |
| ILTEFMENGALDSFL | 691 | P54760 | |
| TLAMDTILANARFFD | 161 | P46926 | |
| TLDMDLVFLFDNSKI | 381 | O14920 | |
| FLAMVFQDLLTNKDD | 476 | Q8N201 | |
| LYLEDSDFLENLMST | 311 | A8MXV4 | |
| INVDDMVNELFDSLF | 161 | P51654 | |
| LQAFFLVADDIMDSS | 161 | P14324 | |
| EVLELFLDPAFFQMD | 1971 | Q9Y3R5 | |
| DFEEMNLSLLSARSF | 631 | Q6VAB6 | |
| AFDLQQMIDEIFLSS | 86 | P98073 | |
| ATDMDSDDSLLLFVL | 586 | Q5SZK8 | |
| DFLLFGVLFEATMID | 426 | A9Z1Z3 | |
| AVIMFILNFEDLAQL | 121 | Q9H252 | |
| FDQLAFIEELFSLMV | 156 | Q9Y6B2 | |
| LAAFLDTFLAANSML | 81 | Q8NDV2 | |
| ISEVLFNELAFFKLM | 1676 | Q15154 | |
| DISESFLLDFFMVSI | 1261 | A6NKB5 | |
| AFDLQERPSFSLLMD | 861 | Q8IVT5 | |
| TQLNELLLFVAAAFM | 201 | P47888 | |
| LLESSVLVAMAFDRF | 111 | Q8NGJ9 | |
| FFFLSNDEMLEILSE | 996 | Q6ZR08 | |
| LNLAAADLLFLFSMA | 66 | Q8TDS7 | |
| LLEEAAALNLSIMFD | 341 | Q9HCC8 | |
| DVATFLALAQDALDM | 186 | Q13087 | |
| DSFLLAVMAIDRFVA | 111 | O60431 | |
| LIIEFDNMFSSATDI | 2491 | Q7Z6Z7 | |
| LEEALLFSGQFMDAL | 6656 | Q9UPN3 | |
| NMAFIFLNRFLDLTD | 1591 | Q9UG01 | |
| YFISELADMDNFLLA | 101 | Q96R84 | |
| ILFLNEACLFEIMFS | 201 | Q6ZMV5 | |
| LLSAMFDFSEKLNSL | 516 | P20393 | |
| EMIFNLADTHLFFND | 411 | O95677 | |
| MDADTLVLANIDDLF | 101 | P46976 | |
| VFDELMDKFSNDLSL | 326 | O15229 | |
| DIIQSMASFFAIEDL | 566 | Q9BXC9 | |
| EVLTRFFMDQASFEL | 1026 | Q9H7D0 | |
| FFLNDLLSVMDRGFV | 1076 | Q96N67 | |
| NQFLDELMELEIFLA | 351 | Q96JB5 | |
| AFDLVMLLNDPDTEL | 396 | Q68DC2 | |
| FTILEDFLDIMNEQA | 156 | Q6ZWL3 | |
| ASIDLLEDVFSNLDM | 566 | Q8TEH3 | |
| EDVLSTDMIFNNFLA | 2366 | Q14204 | |
| ENVAAIFLGLLDFFM | 2256 | Q8NDH2 | |
| SDLELMAQSIIFIFA | 291 | P24462 | |
| VFVDFLLEDFILNMQ | 81 | Q6DWJ6 | |
| QDLAFLSMLNDIAAV | 446 | P49327 | |
| SLRFLQLELSEMEAF | 171 | Q8NFJ9 | |
| FLFLSGLIMASAIEE | 91 | Q8WWT9 | |
| AADMILLDDNFASIV | 756 | P20648 | |
| LVLLMFNEGEEFSLE | 751 | Q13620 | |
| FIVNLALADLCMAAF | 71 | P21452 | |
| NNEVIFMALDLASLA | 86 | Q6UX07 | |
| DLSDFYMSQDVFLLI | 581 | Q93100 | |
| DNTLLTEFILFLMAV | 186 | Q8NGT5 | |
| NFLLLGFAEDSDMQL | 11 | O60412 | |
| DMSTAELTDFILAIF | 196 | O95222 | |
| FFELDAMDHLQSFIA | 81 | Q9Y383 | |
| FAMKFNALELDDSDI | 361 | Q07869 | |
| MDLTLFAAEAIALNR | 396 | Q9BUB5 | |
| FLFGVDEQLLSALVM | 196 | Q9BXD5 | |
| LFADILNDVAMFLEI | 166 | Q96GQ5 | |
| LIALFDTLLLNFMEV | 1211 | Q86VV8 | |
| SDKNALFNLMFLDLD | 201 | O75691 | |
| DMFLDLLNFAAETLV | 351 | Q7Z4G4 | |
| AMFGSFLVLLTLDDD | 806 | Q8NBJ9 | |
| LLQFAVAEFMDEPDF | 121 | Q8TEB9 | |
| MALRELNIAFNFLTD | 466 | Q9BXR5 | |
| ELMDFITQNLFTGLD | 286 | Q7RTY7 | |
| SLLDLFLDMEAATGQ | 91 | O00231 | |
| NDEFFMDFLQTLLVG | 26 | P0DMR2 | |
| FLDSEVNLFLVPFMD | 421 | Q9H0W8 | |
| LLNLAVADELFMLSV | 86 | P31391 | |
| VDFLLAQGASIALMD | 1116 | Q9HCD6 | |
| FIQAADLLMADFKVL | 371 | Q9NWF9 | |
| SFMDLKALLSSLNDF | 26 | Q9GZT8 | |
| MNDSLFVSLDRLLLE | 1 | Q8N1H7 | |
| MLLTLGLDSQFAFLE | 391 | Q99884 | |
| QLLCFPFALDMDADL | 986 | Q9NRP7 | |
| FMILLSSGALAFEDI | 1226 | P35498 | |
| ELDFLMEALIISKFN | 1161 | Q9UM73 | |
| MLLEQFSFDIAEEAS | 316 | P78536 | |
| AADMILLDDNFASIV | 751 | Q13733 | |
| TQLMLEALDGFFLAI | 111 | O15516 | |
| DFDFLKNLSLEELQM | 436 | Q13188 | |
| IDNVAILFNFLMDFL | 821 | Q9C0E2 | |
| TFIDALRDLDDALSM | 126 | O00541 | |
| AAVMAFLFDLKDLVD | 396 | P30825 | |
| ADSDQLFRMVAEVFI | 3286 | Q15413 | |
| SPEDAMEIQLFFELA | 361 | P47872 | |
| FMILLSSGALAFEDI | 1216 | Q99250 | |
| LVGEVMEFLADLLFF | 986 | Q6P2S7 | |
| LVDFPINDLDMSEFL | 851 | Q9Y4E8 | |
| FMILLSSGALAFEDI | 1206 | Q9UQD0 | |
| AFEQTMFLSRALEEI | 701 | Q8IYF3 | |
| EQAMLEDTLVALFDL | 1331 | Q70Z35 | |
| NDEFFMDFLQTLLVG | 26 | Q8TD33 | |
| AEAQLAELDLLASMF | 36 | P57060 | |
| ALMLHIDSFIENLFA | 216 | Q92973 | |
| FLVFSQMLAGLDLDL | 756 | Q8IUG5 | |
| MASSAELDFNLQALL | 1 | Q56P42 | |
| AMFFNRLSLEFLAIE | 96 | E9PQX1 | |
| IMNLLLAVVFDTFND | 311 | Q9ULQ1 | |
| AEIMLFSLDLLLFST | 11 | Q7Z5H4 | |
| VLSALFDFLLIEAMQ | 101 | Q8NBM4 | |
| DAQEFSKLFMSLLED | 181 | Q86UV5 |